User profiles for "author:Kyoung-Mee Kim"

Kyoung-Mee Kim

Pathology & Translational Genomics, Samsung Medical Center, Sungkyunkwan University
Verified email at skku.edu
Cited by 23187

Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

R Cristescu, J Lee, M Nebozhyn, KM Kim, JC Ting… - Nature medicine, 2015 - nature.com
Gastric cancer, a leading cause of cancer-related deaths, is a heterogeneous disease. We
aim to establish clinically relevant molecular subtypes that would encompass this …

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

ST Kim, R Cristescu, AJ Bass, KM Kim, JI Odegaard… - Nature medicine, 2018 - nature.com
Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a
subset of patients with metastatic gastric cancer (mGC). With the goal of identifying …

[PDF][PDF] Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric …

J Lee, DH Lim, S Kim, SH Park, JO Park, YS Park… - J clin oncol, 2012 - academia.edu
Purpose The ARTIST (Adjuvant Chemoradiation Therapy in Stomach Cancer) trial was the
first study to our knowledge to investigate the role of postoperative chemoradiotherapy …

[HTML][HTML] Molecular testing for gastrointestinal cancer

HS Lee, WH Kim, Y Kwak, J Koh… - … of pathology and …, 2017 - synapse.koreamed.org
With recent advances in molecular diagnostic methods and targeted cancer therapies,
several molecular tests have been recommended for gastric cancer (GC) and colorectal …

[HTML][HTML] Epstein-Barr virus-associated gastric carcinoma and specific features of the accompanying immune response

J Cho, MS Kang, KM Kim - Journal of gastric cancer, 2016 - ncbi.nlm.nih.gov
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is one of the four subtypes of
gastric carcinoma (GC), as defined by the novel classification recently proposed by The …

[HTML][HTML] Glomus tumor of the stomach: a clinicopathologic analysis of 10 cases and review of the literature

G Kang, HJ Park, JY Kim, D Choi, BH Min, JH Lee… - Gut and liver, 2012 - ncbi.nlm.nih.gov
Methods In this study, we analyzed 10 cases of gastric glomus tumors resected at a single
institute over 9 years. Results Eight of the patients were men and 2 were women, with a …

[PDF][PDF] Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the …

SH Park, TS Sohn, J Lee, DH Lim, ME Hong… - Journal of clinical …, 2015 - niioncologii.ru
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus
Concurrent Chemoradiotherapy in Gastric Page 1 Phase III Trial to Compare Adjuvant …

Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis

MC Camargo, WH Kim, AM Chiaravalli, KM Kim… - Gut, 2014 - gut.bmj.com
Background and objective About 9% of gastric carcinomas have Epstein–Barr virus (EBV) in
the tumour cells, but it is unclear whether viral presence influences clinical progression. We …

[HTML][HTML] Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter …

MY Cho, JM Kim, JH Sohn, MJ Kim… - … : official journal of …, 2012 - synapse.koreamed.org
Purpose As a result of various independently proposed nomenclatures and classifications,
there is confusion in the diagnosis and prediction of biological behavior of …

Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer

F Pietrantonio, R Miceli, A Raimondi… - Journal of Clinical …, 2019 - discovery.ucl.ac.uk
PURPOSE: In the CLASSIC and MAGIC trials, microsatellite instability (MSI)–high status was
a favorable prognostic and potential negative predictive factor for neoadjuvant/adjuvant …